Open help menu
Live Webinar
Intellectual and Developmental Disabilities (IDD) and Co-Occurring Behavioral Health Needs: Louisiana

EBP Modifications and Psychopharmacology Considerations for Individuals with IDD

Brandi Kelly, PhD
James R Logan, PhD, MP
|

Information

Date & Time

Description

Individuals with IDD are more likely to experience behavioral health conditions than individuals without IDD. Considerable research exists on the efficacy of behavioral health treatment including evidence based practices (EBPs). Core EBPs including trauma-focused CBT, DBT, Eye Movement Desensitization and Reprocessing, multi-systemic therapy, Assertive Community Treatment, and triple P parenting can be engaged and beneficial for individuals with IDD and mental health needs. This training will include a review of research on the efficacy of these EBPs for individuals with IDD and outline modifications and additional resources clinicians can pursue. Additionally, individuals with IDD have historically experienced overuse of psychotropic medications including usage as chemical restraint. Appropriate use of medication can be an important part of mental health treatment. This training will cover important considerations in using psychotropic medication as part of comprehensive approach to treatment.

Learning Objectives

Participants will be able to:

  • Participants will be able to identify at least 2 essential modification considerations that apply across therapeutic approaches.

  • Participants will be able to identify at least 2 evidenced based practices and associated modifications for effectiveness with individuals with IDD

  • Participants will be able to identify core prescribing practices that are the same and at least 2 unique considerations for individuals with IDD

  • Participants will be able to identify and provide examples of at least 2 monitoring practices that are essential when an individual needs support to take medication and communicate with their prescriber

Educational Goal

To increase knowledge of behavioral health conditions in individuals with IDD and core modifications for evidence based practices to achieve positive outcomes. To increase awareness of psychopharmacology considerations for effective use of medication as part of mental health treatment.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Psychologist
  • Social Worker

Presenters

Brandi Kelly, PhD
Dr. Brandi Kelly, PhD, received her doctoral degree in clinical psychology from LSU in 1998 and post-doctoral master’s degree in clinical psychopharmacology from Alliant University in 2002. She has worked extensively providing person-centered and wellness focused support planning and behavioral health services to individuals with developmental disabilities and has published research on assessment/treatment of behavioral health concerns of individuals with developmental disabilities. She has been instrumental in key initiatives in Louisiana to increase capacity to support individuals with co-occurring needs to live/work in their communities while navigating the logistics of fiscal/resource challenges in partnership with self-advocates, advocacy organizations, providers, and other state agencies. She received the Bernard R. Wagner Leadership in Developmental Disabilities award, Special Recognition for Enhancing the Wellness of Individuals with IDD from the Arc of Louisiana, and was the 2023 NADD Member of the Year. She currently sits on the NADD Board and Conference Committee. She has published in the area of MH needs and wellness for individuals with IDD.
James R Logan, PhD, MP
Dr. Randy Logan is a Medical Psychologist who has been affiliated with OCDD for almost 30 years. Dr. Logan's tenure with OCDD began at Pinecrest, where he served as Director of Psychology and later as Coordinator of Psychiatry. Dr. Logan's work at Pinecrest occurred in the context of the DOJ/CRIPA investigation and settlement agreement that ran from 1995 through 2007. After the conclusion of DOJ's involvement in Louisiana, Dr. Logan was deployed as the Clinical Director of Northeast Developmental Center and later, in the same capacity, at Northlake Supports and Services Center.

Since 2010, Dr. Logan has been affiliated with the OCDD Resource Center. In his role at the Resource Center, Dr. Logan provides consultation in the interest of increasing the community's capacity to support individuals with ID/DD. A frequent focus of consultation is cases with complex needs at risk for loss of community placement. Dr. Logan also provides leadership in the areas of forensic assessment and psychotropic support. Dr. Logan continues to provide direct services as a "provider of last resort".

Financially Sponsored By

  • Aetna Better Health of Louisiana
  • Humana Healthy Horizons in Louisiana
  • Louisiana Healthcare Connections